Content | Navigation |

Sponsored Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer Seminar Speakers

Upcoming Presentations 


"Synthesis and Applications of Silicone-Based Amphiphilic Triblock Copolymers"

Monday, October 22
2:30 pm
Sudro Hall 26
Luke Theogarajan, Ph.D.
Professor of Electrical and Computer Engineering, University of California, Santa Barbara

Past Presentations

Sushanta K. Banerjee, Ph.D., Research Scientist - VA Medical Center, Kansas City, MO, Research Director - Cancer Research Unit, VAMC, Professor - Department of Anatomy and Cell Biology and Department of Pathology University of Kansas Medical Center, Kansas City, Kansas 

  • “Targeting Triple Negative Breast Cancer by CCN5” - April 10, 2018

Kwaku Baryeh

  • “Carbon Nanotube-based Lateral Flow Biosensor Strips for the Quantitative Detection of Pancreatic Cancer Biomarkers in Human Plasma” (Dr. Liu’s group) - November 28, 2017
  • "Development of Lateral Flow Strip Biosensors for the Detection of Pancreatic Cancer Protein Biomarker: CA 19-9” (Dr. Liu’s group) - May 2, 2017

Dr. Howard Crawford, Professor, Molecular & Cellular Physiology and Internal Medicine; Director, Pancreas Research Program; Director, Animals Models of Pancreas Disease Core, University of Michigan

  • “Pancreatic Tumorigenesis:  When the Going Gets Tough, the Tufts Get Going” – October 11, 2016

Dr. Channing Der, Kenan Distinguished Professor of Pharmacology, Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill

  • “Drugging Undruggable KRAS for Pancreatic Cancer” – October 28, 2016

Kevin P. Francis, Ph.D., Preclinical Imaging, PerkinElmer

  • April 18, 2017

Dr. Raghu Kalluri, Professor, and Chairman, Department of Cancer Biology, The University of Texas Anderson Cancer Center 

  • Date/Title Missing

Dr. Khoda

  • “Bio-manufacturing of Cancerous Pancreas Tissue with Controlled Gradient Scaffold Structure” - February 7, 2017

Dr. Sadagopan Krishnan, Department of Chemistry, Oklahoma State University

  • “Ultrasensitive Clinical Biosensors and Microarrays for Disease Markers” – August 29, 2016 

Dr. Estelle Leclerc

  • “Targeting RAGE in Pancreatic Cancer” - June 13, 2017

Qiaobin Li

  • “Gold/Silica Nanocomposite-based Lateral Flow Nucleic Acid Biosensors for Sensitive Detection of miRNA-196a” (Dr. Liu’s group) - March 21, 2017

Dr. Guodong Liu 

  • “Magnetic Carbon Nanotube for Visual Detection of Pancreatic Cancer Biomarkers in Whole Blood” - July 11, 2017

Jagadish Loganathan

  • “GSTP1 Regulation and JNK Activation in Pancreatic Cancer Cells” (Dr. Reindl’s group) - March 7, 2017 

Yi Lu, Ph.D., Department of Chemistry, Biochemistry, Bioengineering, Department of Materials Science and Engineering, and Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign

  • "Functional DNA Nanotechnology and Its Applications As Theranostic Agents for Sensing, Imaging and Targeted Drug Delivery in Cancer Research" - March 23, 2017

Michelle Lund

  • “Graphene Oxide Assisted SELEX for the Identification of Aptamers for Pancreatic Cancer Biomarkers” (Dr. Liu’s group) - February 21, 2017

Jiyan Mohammad

  • “CRISPR/Cas9 Loss-of-function Library Screen to Identify Genes that Regulate Sensitivity of Pancreatic Cancer Cells to Piperlongumine” (Dr. Reindl’s group) - December 12, 2017
  • “Organotypic and Next Generation Culture Methods” (Dr. Reindl’s group) - January 24, 2017

Dr. Mohi Quadir 

  • “Spatially-controlled, Combination Drug Delivery Platform Using pH-responsive Polymersomes for Pancreatic Cancer” - July 25, 2017

Dr. Steven Qian

  • “New Paradigm of COX-2 Biology on Its Interaction with omega-6s along with Delta-5 Desaturase Inhjibition in Revolutionizing Cancer Treatment” - January 9, 2018

Priyanka Ray

  • “pH Responsive Polymeric Nanoparticles as Efficient Drug Delivery Agents for Pancreatic Cancer” (Dr. Quadir's Group) - October 3, 2017 

Dr. Katie Reindl 

  • “Combination Therapy:  Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine” - June 27, 2017

Dr. Rajesh Sardar, Associate Professor, Department of Chemistry and Chemical Biology, Indiana University – Purdue University Indianapolis

  • “PCR-Free Pancreatic Cancer Biomarker Assay in Blood:  From Bench-top to Bedside” – November 3, 2016

Thomas D. Schmittgen, Ph.D., Professor of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, Florida

  • “A MicroRNA and Pancreatic Cancer Link:  Implications for Therapy and Early Detection” - April 19, 2018

Rahul Singh

  • "GSTP1 knockdown and inhibition impairs pancreatic ductal adenocarcinoma growth (PDAC)" (Dr. Reindl’s group)  - May 2, 2017
  • “GSTP1 Knockdown Impairs the Growth and Proliferation of Pancreatic Ductal Adenocarcinoma (PDAC) Cells” (Dr. Reindl’s Group) - November 14, 2017

Dr. Silvia Stan, Assistant Professor, Department of Nutrition Science, Purdue University

  • “Insights into the Pleiotropic Nature of Dietary Bioactives” – October 21, 2016

Priyanka Swami

  • "Targeting RAGE in Pancreatic Cancer" (Dr. Leclerc’s group) - January 17, 2017
  • “Targeting RAGE in Pancreatic Cancer” (Dr. Leclerc’s Group) - October 17, 2017

Sunitha Takalkar

  • “Development of Lateral Flow Nucleic Acid Biosensors for the Detection of Pancreatic Cancer miRNA Biomarkers” (Dr. Liu’s group) - April 18, 2017

Sakshi Taneja

  • “In-vitro Study of AGE-RAGE Interaction on Pancreatic Cancer Using Prairie KPC Cell Lines” (Dr. Leclerc’s Group) - October 31, 2017 

Benjamin A. Teply, M.D., Assistant Professor, Internal Medicine, Division of Oncology & Hematology, UNMC Oncology/Hematology Division

  • “Therapeutic Opportunities in the Rapidly Changing Treatment Paradigm for Advanced Prostate Cancer" - July 16, 2018

Daniel M. Tuvin, M.D., General Surgery, Surgical Oncology, Sanford Broadway Clinic

  • "The Current State of Diagnosis and Treatment of Pancreatic Cancer" - April 4, 2017

Dr. John Wilkinson

  • “Metabolic Regulation of Pancreatic Cancer by Apoptosis Including Factor” - January 10, 2017                  

Dr. Yan Zhang

  • “Manufacturing Pancreatic Cancer Tissue Microarrays Using 3D Tumor Spheroids” - January 17, 2017

Dr. Mohi Quadir

  • “Spatially-controlled, Combination Drug Delivery Platform Using pH-responsive Polymersomes for Pancreatic Cancer” - July 25, 2017

Student Focused. Land Grant. Research University.

Follow NDSU
  • Facebook
  • Twitter
  • RSS
  • Google Maps

North Dakota State University
Phone: +1 (701) 231-5192
Campus address: Sudro Hall 102
Physical/delivery address: 1401 Albrecht Blvd, 136 Sudro Hall, Fargo, ND 58102
Mailing address: NDSU Dept. 2665 / PO Box 6050 / Fargo, ND 58108-6050
Page manager: NDSU Department of Pharmaceutical Sciences

Last Updated: Wednesday, October 03, 2018 11:55:55 AM
Privacy Statement